Evidence map›Paper›PMID 31731523›Full record

ArticleCells2019

Regulation of Mitochondria-Associated Membranes (MAMs) by NO/sGC/PKG Participates in the Control of Hepatic Insulin Response.

Arthur Bassot, Marie-Agnès Chauvin, Nadia Bendridi, Jingwei Ji-Cao, Guillaume Vial, Léa Monnier, Birke Bartosch, Anaïs Alves, Cécile Cottet-Rousselle, Yves Gouriou and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Developing aMarine drugs · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. The Role of Melatonin in Electroacupuncture Alleviating Lung Injury Induced by Limb Ischemia-Reperfusion in Rabbits.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Arthur BassotCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, 69008 Lyon, France.ORCID 0000-0002-4276-4493
Marie-Agnès ChauvinCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, 69008 Lyon, France.
Nadia BendridiCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, 69008 Lyon, France.
Jingwei Ji-CaoCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, 69008 Lyon, France.
Guillaume VialHP2 Laboratory, INSERM U 1042, University Grenoble Alpes, 38000 Grenoble, France.ORCID 0000-0002-7333-8526
Léa MonnierCancer Research Centre (CRCL), INSERM U1052, 69008 Lyon, France.
Birke BartoschCancer Research Centre (CRCL), INSERM U1052, 69008 Lyon, France.ORCID 0000-0001-6354-4660
Anaïs AlvesCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, 69008 Lyon, France.
Cécile Cottet-RousselleLaboratory of Fundamental and Applied Bioenergetics (LBFA), INSERM U 1055, University Grenoble Alpes, 38000 Grenoble, France.
Yves GouriouCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, 69008 Lyon, France.
Jennifer RieussetCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, 69008 Lyon, France.
Béatrice MorioCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, 69008 Lyon, France.ORCID 0000-0002-2418-1438
Université Claude Bernard Lyon 1 · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Under physiological conditions, nitric oxide (NO) produced by the endothelial NO synthase (eNOS) upregulates hepatic insulin sensitivity. Recently, contact sites between the endoplasmic reticulum and mitochondria named mitochondria-associated membranes (MAMs) emerged as a crucial hub for insulin signaling in the liver. As mitochondria are targets of NO, we explored whether NO regulates hepatic insulin sensitivity by targeting MAMs. In Huh7 cells, primary rat hepatocytes and mouse livers, enhancing NO concentration increased MAMs, whereas inhibiting eNOS decreased them. In vitro, those effects were prevented by inhibiting protein kinase G (PKG) and mimicked by activating soluble guanylate cyclase (sGC) and PKG. In agreement with the regulation of MAMs, increasing NO concentration improved insulin signaling, both in vitro and in vivo, while eNOS inhibition disrupted this response. Finally, inhibition of insulin signaling by wortmannin did not affect the impact of NO on MAMs, while experimental MAM disruption, using either targeted silencing of cyclophilin D or the overexpression of the organelle spacer fetal and adult testis-expressed 1 (FATE-1), significantly blunted the effects of NO on both MAMs and insulin response. Therefore, under physiological conditions, NO participates to the regulation of MAM integrity through the sGC/PKG pathway and concomitantly improves hepatic insulin sensitivity. Altogether, our data suggest that the induction of MAMs participate in the impact of NO on hepatocyte insulin response.

Indexed as

AnimalsCell Line, TumorCyclic GMP-Dependent Protein KinasesEndoplasmic ReticulumGlucoseHepatocytesHumansInsulinInsulin ResistanceLiverMaleMiceMice, Inbred C57BLMitochondriaMitochondrial MembranesNitric OxideCyclic GMP-Dependent Protein KinasesGlucoseInsulinNitric OxideNitric Oxide Synthase Type IIISoluble Guanylyl CyclaseWortmannincyclic guanosine monophosphate (cGMP)-dependent protein kinasehepatic glucose metabolismmetabolic flexibilitymitochondria-associated endoplasmic reticulum membranesnitric oxide

Identifiers

PMID31731523
PMCPMC6912364
OpenAlexW2982143919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.